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ABSTRACT
Objective: We evaluated the effect of maternal administration of ampicillin/sulbactam on coloniza-
tion and bacteremia in newborn rabbits after intracervical inoculation of mothers with group B
streptococci (GBS).
Methods: New Zealand white rabbits on day 30 of a 31-day gestation were inoculated intracer-
vically with 104-105 colony forming units (cfu) GBS. Two hours after inoculation mothers received
ampicillin/sulbactam (50 mg/kg) or saline (control) intramuscularly as a single dose, in a random-
ized double-blinded manner. We induced labor 4 h later with intramuscular oxytocin. At delivery,
cultures for GBS were taken from neonatal oropharynx. Thereafter, cultures were taken from
neonatal oropharynx and anorectum daily and from neonatal heart at death or after 96 h. Sample
size analysis showed a need for 17 pups in each group.
Results: In the control group, induction failed in one animal that was excluded from analysis. At
birth, 0 of 39 pups of treated does had positive oropharyngeal cultures compared to 26 of 27 (96%)
pups of saline-treated does (P < 0.0001). Pups treated with antibiotic in utero were also significantly
less likely to have positive oropharyngeal cultures at 24, 48, and 72 h after birth compared to
controls (24 h, 0% vs. 100%, P < 0.0001; 48 h, 8% vs. 100%, P < 0.0001; 72 h, 16% vs. 100%, P <
0.0001). Treated pups were significantly less likely to have positive anorectal cultures at 24, 48, and
72 h after birth compared to control animals (24 h, 0% vs. 100%, P < 0.0001; 48 h, 0% vs. 95%,
P < 0.0001; 72 h, 0% vs. 92%, P < 0.0001). Treated pups were significantly less likely to have positive
heart cultures at 72 h after birth compared to controls (11% vs. 92%, P < 0.0002). Cumulative
neonatal survival was higher in treated pups compared to controls at 72 and 96 h after birth (72 h,
32% vs. 0%, P 0.0003; 96 h, 26% vs. 0%, P 0.015).
Conclusions: Single dose transplacental prophylaxis given 4 h before delivery resulted in de-
creased neonatal GBS colonization and bacteremia and improved neonatal survival in rabbits.
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n 1996, the Centers for Disease Control (CDC)
and the American College of Obstetricians and
Gynecologists (ACOG)z published recommenda-
tions for prevention of early onset neonatal group B
streptococcal (GBS) sepsis by intrapartum chemo-
prophylaxis. Although several clinical trials in hu-
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mans have demonstrated that the use of intrapar-
tum prophylaxis can reduce cases of sepsis in in-
fants,3-8 only one trial showed a statistically
significant reduction, and none used a randomized,
placebo-controlled experimental design. In a meta-
analysis, Ohlsson and Myhr
9 argued that the effec-
tiveness of intrapartum prophylaxis has not been
rigorously shown.
We believe that our rabbit model of ascending
infection in pregnancy may provide important in-
formation relevant to the pathogenesis and preven-
tion of GBS sepsis in human newborns. In past
work, we have demonstrated that inoculation of the
rabbit cervix with GBS at 70% gestation led to high
rates of clinical intra-amniotic infection in un-
treated animals.1 Recently, we treated pregnant
rabbits with antibiotic or saline, induced labor, and
inoculated the oropharynx of each pup with GBS.
Pups born to antibiotic-treated mothers had signifi-
cantly decreased neonatal colonization and bacter-
emia1 compared to pups born to saline-treated
mothers. In the present work, we have sought to
more closely mimic vertical transmission in humans
by inoculating the cervix of the mother prior to
delivery. We have tested the hypothesis that a
single dose of antibiotic administered prior to labor
reduces neonatal GBS colonization and sepsis.
SUBJECTS AND METHODS
This protocol was approved by the Animal Use and
Care Committee at the University of Colorado
Health Sciences Center. We used timed pregnant
New Zealand white rabbits with a 31-day gestation.
We obtained these animals from approved vendors
(Myrtle’s Rabbitry, Thompson Station, TN).
On day 30 (97% of gestation), the maternal cer-
vices were inoculated with 104-10s colony forming
units (cfn) type Ia GBS endoscopically with a tech-
nique previously described. In previous experi-
ments, this inoculum size has led to clinical intra-
amniotic infection. In brief, animals were anesthe-
tized and an endoscope was placed in the vagina
and advanced to the cervix. Under direct visualiza-
tion, a cannula was advanced through the operating
port into the cervix, and a bacterial inoculum was
given. The animals were then returned to their
cages.
Two hours after inoculation, mothers received
either 50 mg/kg ampicillin/sulbactam 11 or sterile
saline intramuscularly in a blinded manner. This
dose of ampicillin for a 4 kg rabbit would have been
equal to 2.6 g in a 70 kg human. A schedule of
group assignments was generated from a table of
random numbers. Two animals were inoculated
each time the experiment was performed. Syringes
containing antibiotic or saline were wrapped with
tape to prevent the investigators from knowing the
color of the solution. These syringes were labeled
with the rabbit’s experimental number. Four hours
after treatment (6 h after inoculation), labor was
induced with oxytocin intramuscularly. Delivery
usually occurred within 30 min. At delivery, viabil-
ity was assessed, and cultures for GBS were taken
from the pups’ oropharynges. Thereafter, pups
were observed on a daily basis for up to 96 h. Sy-
ringe feeding was necessary for most pups because
of rejection by the mother.
Swabs for culture were collected from the oro-
pharynx and anorectum of each pup daily and
plated onto 5% sheep blood agar or into selective
broth media (Todd-Hewitt broth containing nali-
dixic acid and gentamicin) with subculture onto 5%
sheep blood agar. Blood for culture was taken from
the neonatal heart at death or after 96 h. GBS were
identified by Gram stain, catalase test, and the
Christie-Atkins-Munch-Petersen (CAMP) test.
Outcomes measured were the rates of 1) positive
culture for GBS at each site (oropharynx, anorec-
turn, and heart) for each 24-h period, and 2) cumu-
lative neonatal survival for each 24-h period. We
used Fisher’s exact test and chi-square analysis to
compare rates. We considered P < 0.05 to be sig-
nificant.
For sample size analysis, we assumed that alpha
0.05, beta 0.2, the proportion of positive oro-
pharyngeal cultures in the placebo group of 90% at
24 h after delivery, and a difference in proportion
between antibiotic and placebo groups of 50%.
With these assumptions, a total of 17 pups were
required in each group. Since the litter size varied
from 4 to 8, we estimated that a total of 5 mothers
in each group would be required.
RESULTS
Five does were randomized to each group. In the
control group, induction of labor failed in one ani-
mal that was excluded from analysis. Table shows
the positive neonatal oropharyngeal cultures by
time from delivery and treatment group. From
birth through 72 h, pups born to antibiotic-treated
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TABLE I. Positive neonatal oropharyngeal cultures
by time from delivery and treatment group
Time Ampicillin/sulbactam Saline P
Birth 0/39 26/27 (96%) <0.000
24 h 0/31 22/22 (I 00%) <0.000
48 h 2/26 (8%) 19/19 (I 00%) <0.0001
72 h 3/I 9 (I 6%) 13/I 3 (I 00%) <0.00
96 h 0/10 0/0 NA
NA not applicable.
mothers had significantly fewer positive cultures
than pups born to controls. We obtained similar
results for neonatal anorectal cultures at 24, 48, and
72 h after birth (Table 2). Compared to the control
group, the treated pups had less bacteremia at 24,
48, and 72 h with statistical significance achieved at
72 h (Table 3). Because all of the pups in the con-
trol group died by 72 h, no results are available at
96 h in Tables 1-3. Table 4 shows the cumulative
neonatal survival by time from delivery and treat-
mcnt group. At both 72 and 96 h after delivery,
significantly more pups survived in the treated
group compared to the control group.
DISCUSSION
This experiment provides the first blinded, pla-
cebo-controlled evidence, in any species, that ma-
ternal chemoprophylaxis prevents vertical trans-
mission of GBS and neonatal colonization and sep-
sis. A single intramuscular dose of ampicillin/
sulbactam, given 4 h before delivery, dramatically
improved outcomes in this model. We demon-
strated significantly lower rates of neonatal coloni-
zation of the oropharynx not only at birth but also
within 72 h of birth. We found lower rates of posi-
tive neonatal heart cultures in the antibiotic-
treated group at 48 and 72 h after birth. Our highest
rates of neonatal survival in the treated group at 72
and 96 h after birth correlated with the timing of
the lowest rates of positive neonatal heart cultures.
These striking results in the rabbit are subject to
several limitations when compared to women.
First, we administered the antibiotic intramuscu-
larly rather than intravenously as in humans. Sec-
ond, we knew the exact time of the beginning of
infection. Third, we studied only one time interval
from antibiotic administration to delivery, namely 4
h. We cannot comment on whether a shorter or
longer interval would produce equivalent results.
In humans, bactericidal concentrations of ampicil-
TABLE 2. Positive neonatal anorectal cultures by
time from delivery and treatment group
Time Ampicillin/sulbactam Saline P
24 h 0/31 22/22 (100%) <0.000
48 h 0/26 18/19 (95%) <0.0001
72 h 0/19 12/I 3 (92%) <0.000
96 h 0/10 0/0 NA
aNA not applicable.
TABLE 3. Positive neonatal heart cultures by time
from delivery and treatment group
Time Ampicillin/sulbactam Saline P
24 h 0/2 3/3 (I 00%) NA
48 h 3/10 (30%) 5/6 (83%) 0.12
72 h I/9 (I I%) 12/13 (92%) 0.002
96 h 0/10 0/0 NA
NA not applicable.
TABLE 4. Cumulative neonatal survival by time
from delivery and treatment group
Ampicillin/sulbactam Saline
Time (N 31) (N 22) P
24 h 29 (94%) 19 (86%) NS
48 h 19 (61%) 13 (59%) NS
72 h 10 (32%) 0 0.003
96 h 8 (26%) 0 0.015
aNS not significant.
lin in the fetal serum and amniotic fluid have been
documented as soon as 5 min after maternal ampi-
cillin injection, le We believe that the ampicillin
portion of ampicillin/sulbactam resulted in the
clinical effect seen. Although all treated pups had
negative oropharyngeal cultures at birth and at 24
h, some pups later developed positive oropharyn-
geal and heart cultures. Possible explanations in-
clude a failure of the culture to detect low-level
colonization initially present or cross-contamina-
tion within a litter. Further, our experimental pro-
tocol did not provide continued antibiotic treat-
ment after delivery as advocated in some human
situations by the CDC and ACOG guidelines. In
the current work, 21 (68%) pups in the treated
group died by 72 h after inoculation. Although
some of these deaths were associated with GBS
bacteremia (4/21, 19%), most were the result of the
interruption of nesting behavior. Nevertheless, the
results clearly show significantly fewer deaths with
bacteremia in the treated group. Finally, in the un-
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treated group, early neonatal mortality was 100%.
In humans, although vertical transmission of GBS
from mothers to infants is 50-70%, invasive GBS
disease occurs in only 1% of colonized neonates.
We believe these experiments represent an im-
portant advance in our work on the pathogenesis of
GBS disease in this animal model. In early experi-
ments, we demonstrated that intracervical inocula-
tion of GBS into rabbits at 70% gestation led to
fulminant intra-amniotic infection in all cases.1
We attempted to establish a model of chronic vagi-
nal carriage of GBS similar to humans but found
that vaginal inoculation led to clinical and micro-
biologic evidence of infection in nearly 50% of
cases.
1" To study rates of neonatal GBS coloniza-
tion and sepsis after maternal antibiotic adminis-
tration, we then inoculated pups orally after induc-
tion of labor. We found that a single dose of anti-
biotic administered to the mother within 2-6 h of
birth led to lower rates of neonatal colonization and
sepsis compared to a control group.
11 In the present
work, the experimental time sequence of inocula-
tion, treatment, and delivery more closely mimics
the situation in humans.
Despite the obvious interspecies differences, we
believe that this model demonstrates some impor-
tant features of neonatal GBS disease in humans.
First, vertical transmission led to a high neonatal
colonization rate as in humans. Second, coloniza-
tion led to invasive disease and neonatal death.
Third, a single dose of antibiotic prophylaxis 4 h
prior to delivery was effective in lowering coloni-
zation rates and death with bacteremia. We con-
clude that the results of these experiments provide
the first blinded, placebo-controlled evidence that
intrapartum chemoprophylaxis reduces the rate of
GBS sepsis in neonates.
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